Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03570619
Title Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations (IMPACT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Michigan Rogel Cancer Center
Indications

prostate adenocarcinoma

carcinoma

Therapies

Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST